Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Stefan Carlsson, Ola Bratt, Dushanka Kristiansson & Fredrik Jäderling. (2020) The value of a first MRI and targeted biopsies after several years of active surveillance for low-risk prostate cancer – results from the SAMS trial. Scandinavian Journal of Urology 54:4, pages 318-322.
Read now
Read now
Stacy Loeb, Yasin Folkvaljon, David Robinson, Danil V. Makarov, Ola Bratt, Hans Garmo & Pär Stattin. (2016) Immediate versus delayed prostatectomy: Nationwide population-based study. Scandinavian Journal of Urology 50:4, pages 246-254.
Read now
Read now
Frederik B. Thomsen, Kasper D. Berg, M. Andreas Røder, Peter Iversen & Klaus Brasso. (2015) Active surveillance for localized prostate cancer: An analysis of patient contacts and utilization of healthcare resources. Scandinavian Journal of Urology 49:1, pages 43-50.
Read now
Read now
Lars Lund, Niels Svolgaard & Mads Hvid Poulsen. (2014) Prostate cancer: a review of active surveillance. Research and Reports in Urology 6, pages 107-112.
Read now
Read now
Antti Rannikko. (2013) Editorial Comment to: SAMS: A randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer. Scandinavian Journal of Urology 47:5, pages 356-356.
Read now
Read now
Articles from other publishers (17)
Vineetha Thankapannair, Alexandra Keates, Tristan Barrett & Vincent J. Gnanapragasam. (2023) Prospective Implementation and Early Outcomes of a Risk-stratified Prostate Cancer Active Surveillance Follow-up Protocol. European Urology Open Science 49, pages 15-22.
Crossref
Crossref
Anirudh Tomer, Daan Nieboer, Monique J. Roobol, Anders Bjartell, Ewout W. Steyerberg, Dimitris Rizopoulos, Bruce Trock, Behfar Ehdaie, Peter Carroll, Christopher Filson, Jeri Kim, Christopher Logothetis, Todd Morgan, Laurence Klotz, Tom Pickles, Eric Hyndman, Caroline Moore, Vincent Gnanapragasam, Mieke Van Hemelrijck, Prokar Dasgupta, Chris Bangma, Arnauld Villers, Antti Rannikko, Riccardo Valdagni, Antoinette Perry, Jonas Hugosson, Jose Rubio‐Briones, Lukas Hefermehl, Lee Lui Shiong, Mark Frydenberg, Yoshiyuki Kakehi, Mikio Sugimoto, Theo van der Kwast, Henk Obbink, Wim van der Linden, Tim Hulsen, Cees de Jonge, Mike Kattan, Ji Xinge, Kenneth Muir, Artitaya Lophatananon, Michael Fahey, Liying Zhang, Kerri Beckmann, Brian Denton, Andrew Hayen, Paul Boutros, Wei Guo, Nicole Benfante, Janet Cowan, Dattatraya Patil, Emily Tolosa, Tae‐Kyung Kim, Alexandre Mamedov, Vincent LaPointe, Trafford Crump, Vasilis Stavrinides, Jenna Kimberly‐Duffell, Aida Santaolalla, Jonathan Olivier, Tiziana Rancati, Helén Ahlgren, Juanma Mascarós, Annica Löfgren, Kurt Lehmann, Catherine Han Lin, Hiromi Hirama, Kwang Suk Lee, Guido Jenster, Anssi Auvinen, Masoom Haider, Kees van Bochove, Ballentine Carter, Sam Gledhill, Mark Buzza, Michelle Kouspou, Sophie Bruinsma & Jozien Helleman. (2020) Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance. BJU International 127:1, pages 96-107.
Crossref
Crossref
Amit Ghose, Makarand Khochikar, Ravindra Sabnis, Naveen Magendra Parmar & Indranil Purkait. (2020) Expert Group Consensus Opinion on Prostate Cancer Diagnosis and Management in India: Part 1 of 2. The Korean Journal of Urological Oncology 18:3, pages 170-182.
Crossref
Crossref
Gregory S. Merrick, Ava Tennant, Ryan Fiano, Abbey Bennett, Richard Anderson, Robert Galbreath, Wayne M. Butler & Edward Adamovich. (2019) Active surveillance outcomes in prostate cancer patients: the use of transperineal template-guided mapping biopsy for patient selection. World Journal of Urology 38:2, pages 361-369.
Crossref
Crossref
Ola Bratt, Erik Holmberg, Ove Andrén, Stefan Carlsson, Linda Drevin, Eva Johansson, Andreas Josefsson, Maria Nyberg, Jonas Sandberg, Pär Stattin & David Robinsson. (2019) The Value of an Extensive Transrectal Repeat Biopsy with Anterior Sampling in Men on Active Surveillance for Low-risk Prostate Cancer: A Comparison from the Randomised Study of Active Monitoring in Sweden (SAMS). European Urology 76:4, pages 461-466.
Crossref
Crossref
Alberto Briganti, Nicola Fossati, James W.F. Catto, Philip Cornford, Francesco Montorsi, Nicolas Mottet, Manfred Wirth & Hendrik Van Poppel. (2018) Active Surveillance for Low-risk Prostate Cancer: The European Association of Urology Position in 2018. European Urology 74:3, pages 357-368.
Crossref
Crossref
J. Rubio-Briones, A. Borque-Fernando, L.M. Esteban-Escaño, S. Martínez-Breijo, R. Medina-López & V. Hernández. (2018) Variability in the multicenter National Registry in Active Surveillance: a questionnaire for urologists. Actas Urológicas Españolas (English Edition) 42:7, pages 442-449.
Crossref
Crossref
J. Rubio-Briones, A. Borque-Fernando, L.M. Esteban-Escaño, S. Martínez-Breijo, R. Medina-López & V. Hernández. (2018) Variabilidad dentro del Registro Nacional multicéntrico en Vigilancia Activa; cuestionario a urólogos. Actas Urológicas Españolas 42:7, pages 442-449.
Crossref
Crossref
Mieke Van Hemelrijck, Hans Garmo, Lars Lindhagen, Ola Bratt, Pär Stattin & Jan Adolfsson. (2017) Quantifying the Transition from Active Surveillance to Watchful Waiting Among Men with Very Low-risk Prostate Cancer. European Urology 72:4, pages 534-541.
Crossref
Crossref
Stacy Loeb, Caitlin Curnyn, Angela Fagerlin, Ronald Scott Braithwaite, Mark D. Schwartz, Herbert Lepor, Herbert Ballentine Carter & Erica Sedlander. (2017) Qualitative study on decision-making by prostate cancer physicians during active surveillance. BJU International 120:1, pages 32-39.
Crossref
Crossref
Evan Kovac, Gregory Lieser, Ahmed Elshafei, J. Stephen Jones, Eric A. Klein & Andrew J. Stephenson. (2017) Outcomes of Active Surveillance after Initial Surveillance Prostate Biopsy. Journal of Urology 197:1, pages 84-89.
Crossref
Crossref
Stacy Loeb, Dawn Walter, Caitlin Curnyn, Heather T. Gold, Herbert Lepor & Danil V. Makarov. (2016) How Active is Active Surveillance? Intensity of Followup during Active Surveillance for Prostate Cancer in the United States. Journal of Urology 196:3, pages 721-726.
Crossref
Crossref
Mieke Van Hemelrijck, Hans Garmo, Annette Wigertz, Per Nilsson & Pär Stattin. (2016) Cohort Profile Update: The National Prostate Cancer Register of Sweden and Prostate Cancer data Base—a refined prostate cancer trajectory. International Journal of Epidemiology 45:1, pages 73-82.
Crossref
Crossref
Mariangela Mancini, Michele Zazzara & Filiberto Zattoni. (2016) Stem Cells, Biomarkers and Genetic Profiling: Approaching Future Challenges in Urology. Urologia Journal 83:1, pages 4-13.
Crossref
Crossref
Laurence Klotz. 2016. The Prostate Cancer Dilemma. The Prostate Cancer Dilemma
141
152
.
Marios Hadjipavlou, John Promponas & Sanjeev Madaan. (2015) Active surveillance for low-risk prostate cancer. Journal of Clinical Urology 8:6, pages 420-428.
Crossref
Crossref
Robert F. Wolff, Steve Ryder, Alberto Bossi, Alberto Briganti, Juanita Crook, Ann Henry, Jeffrey Karnes, Louis Potters, Theo de Reijke, Nelson Stone, Marion Burckhardt, Steven Duffy, Gillian Worthy & Jos Kleijnen. (2015) A systematic review of randomised controlled trials of radiotherapy for localised prostate cancer. European Journal of Cancer 51:16, pages 2345-2367.
Crossref
Crossref